Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
A normal serum free light chain kappa/lambda ratio is typically 0.26 to 1.65, though labs using a renal reference range may consider 0.37 to 3.1 normal for people with reduced kidney function. A ratio above or below your lab's range suggests one type of light chain is being overproduced, which can point to conditions such as monoclonal gammopathy of undetermined significance (MGUS), smoldering or active multiple myeloma, AL amyloidosis, or lymphoma, while mildly abnormal results can also stem from kidney disease, infection, or inflammation. How far outside the range your ratio falls matters more than the abnormality itself, and results are always interpreted alongside your kappa and lambda values, protein electrophoresis, blood counts, calcium, and creatinine. There are several important factors to consider before drawing conclusions, including which reference range your lab used and whether the sample was blood or urine, so see below to understand more.
If you are trying to make sense of an abnormal ratio or symptoms like bone pain, fatigue, frequent infections, unexplained weight loss, numbness, or swelling, a few minutes of structured self-assessment can help you organize what you are experiencing before your next appointment. Taking a free, instant, online symptom check can help you clarify which symptoms are most relevant, what questions to raise with your doctor, and how urgently you should seek follow-up care. It does not replace your physician's interpretation of your labs, but it gives you a clearer starting point and a more confident path to next steps.
Last reviewed for medical accuracy: 09/12/2026
When your doctor orders a blood test for free light chains, you may see results for kappa and lambda light chains, plus the kappa / lambda ratio. These measurements help detect and monitor conditions that involve abnormal antibody production, such as monoclonal gammopathies. This guide explains:
Antibodies (immunoglobulins) are made up of heavy chains and light chains. There are two types of light chains:
Normally, these light chains pair with heavy chains to form complete antibodies. Small amounts of unbound (“free”) kappa and lambda light chains circulate in the blood. Lab tests measure the concentration of these free light chains in milligrams per liter (mg/L).
Under healthy conditions, the body produces kappa and lambda light chains in a balanced way. The kappa / lambda ratio helps detect whether one type is produced in excess:
A balanced ratio reflects normal immune activity. An imbalanced ratio suggests an overgrowth of a single clone of plasma cells (as seen in certain blood disorders) or other factors like kidney function.
Different laboratories may have slightly different reference ranges. A commonly accepted normal ratio is:
Here’s how to interpret results within the “normal” range:
When your ratio rises above about 1.65, it suggests excess kappa free light chains relative to lambda. Possible causes include:
A ratio below about 0.26 indicates relatively more lambda free light chains. Possible reasons:
Interpreting your kappa / lambda result should consider:
A single abnormal ratio by itself does not confirm a serious condition. Doctors compare:
If you’re unsure what your lab results might mean in the context of your symptoms, you could try a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gather insights before your next appointment.
Always discuss any abnormal lab result with your healthcare provider. Seek immediate medical care if you experience:
Your doctor will guide you through further testing and treatment options if needed.
Your healthcare provider is the best source for personalized interpretation and advice. If your kappa / lambda ratio falls outside the normal range, follow up promptly to determine the underlying cause and next steps.
(References)
* Ju S, Wang Y, Ni H, Wang X, Jiang P, Kong X, Zhong R. Correlation of expression levels of BLyS and its receptors with multiple myeloma. Clin Biochem. 2009 Mar;42(4-5):387-99. doi: 10.1016/j.clinbiochem.2008.10.024. Epub 2008 Nov 11. PMID: 19028483.
* Van Hoovels L, Vercammen M, Nevejan L, Cornette M, Briers PJ, Deeren D, Van Droogenbroeck J, Fostier K, De Smet D. Serum free light chain analysis: persisting limitations with new kids on the block. Clin Chem Lab Med. 2022 Aug 26;60(9):1440-1448. doi: 10.1515/cclm-2022-0347. Epub 2022 Jul 4. PMID: 35781357.
* Long TE, Indridason OS, Palsson R, Rognvaldsson S, Love TJ, Thorsteinsdottir S, Sverrisdottir IS, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Thorsteinsdottir I, Olafsson I, Thordardottir AR, Eythorsson E, Jonsson A, Gislason G, Olafsson A, Steingrimsdottir H, Hultcrantz M, Durie BGM, Harding S, Landgren O, Kristinsson SY. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study. Blood Cancer J. 2022 Sep 14;12(9):133. doi: 10.1038/s41408-022-00732-3. Epub 2022 Sep 14. PMID: 36100605; PMCID: PMC9470548.
* Morales-García LJ, Lillo Rodríguez RM, Pacheco-Delgado MS. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment. Clin Biochem. 2023 Aug;118:110610. doi: 10.1016/j.clinbiochem.2023.110610. Epub 2023 Jul 8. PMID: 37429509.
* Borai A, Ichihara K, Tamimi W, Masaud A, Sobki S. Establishment of reference intervals for free light chains and immunoglobulins in Saudi population. Clin Chem Lab Med. 2024 Feb 26;62(3):522-529. doi: 10.1515/cclm-2023-0774. Epub 2023 Oct 4. PMID: 37787915.
* Wu AHB, Wang CC. Serum free light chains among twin siblings: is the kappa/lambda ratio genetically determined? Biomarkers. 2024 Mar;29(2):100-104. doi: 10.1080/1354750X.2024.2319308. Epub 2024 Feb 27. PMID: 38353603.
* Bertamini L, Alberge JB, Lee DJ, El-Khoury H, Kim S, Fleming G, Murphy C, Colchie J, Davis MI, Perry J, Lightbody ED, Allam S, Goqwana LN, Philip V, Smyth N, Sakrikar D, Perkins M, Harding S, Troske D, Getz G, Karlson EW, Munshi N, Anderson KC, Trippa L, Marinac CR, Chen WC, Joffe M, Ghobrial IM. Serum free light chains in a racially diverse population including African Americans and populations from South Africa. Blood. 2025 Feb 20;145(8):840-849. doi: 10.1182/blood.2024026078. PMID: 39571144; PMCID: PMC11867122.
* Maeng CV, Rögnvaldsson S, Einarsson Long T, Brieghel C, Hermansen E, Niemann CU, Grønbæk K, Kristinsson SY, Thorsteinsdóttir S. Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis. Blood Cancer J. 2025 Apr 28;15(1):80. doi: 10.1038/s41408-025-01289-7. Epub 2025 Apr 28. PMID: 40295472; PMCID: PMC12037766.
* Einarsson Long T, Rognvaldsson S, Thorsteinsdottir S, Sverrisdottir IS, Eythorsson E, Oskarsson JT, Indridason OS, Palsson R, Aspelund T, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Thorsteinsdottir I, Olafsson I, Thordardottir AR, Jonsson A, Gislason G, Olafsson A, Hultcrantz M, Durie BGM, Harding S, Love TJ, Landgren O, Kristinsson SY. New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. JAMA Oncol. 2025 Jul 1;11(7):753-761. doi: 10.1001/jamaoncol.2025.1285. PMID: 40440024; PMCID: PMC12123532.
* Milani P, Sanna GD, Bellofiore C, Nuvolone M, Basset M, Mussinelli R, Mazzini G, Nanci M, Ciardo M, Caminito S, Ghazi Esfahani M, Sadrzadeh M, Fogliani A, Benigna F, Guida G, Salinaro F, Bosoni T, Barassi A, Foli A, Albertini R, Perlini S, Merlini G, Palladini G. Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis. JACC CardioOncol. 2025 Oct;7(6):751-759. doi: 10.1016/j.jaccao.2025.07.012. Epub 2025 Sep 11. PMID: 40938239; PMCID: PMC12790041.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.